This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

22 Sep 2021

Recro Pharma backs sustainability programme with 'green' energy transaction

The agreement will contribute toward the equivalent reduction of 937,426 tons of carbon dioxide emissions

Recro Pharma has signed an agreement to purchase 1.2 million renewable energy credits (RECs) with Georgia Power Simple Solar Program.

The purchase will not only support the generation of renewable electricity from low- or zero-emission resources, it will also reduce the emissions associated with the company’s electricity consumption.

As part of Georgia Power’s Simple Solar Program, a REC is created for every megawatt-hour (MWh) of electricity that is generated and delivered to the power grid from a renewable energy source.

The RECs purchased by Recro Pharma contribute toward the equivalent reduction of 937,426 tons of carbon dioxide (CO2) emissions and serve as a key component of the company’s ongoing environmental sustainability programme.

Erica Raether, Recro’s vice president of people, culture and ESG said this latest action, which is part of the company's commitment to efficiently utilise energy, water and materials, while minimising waste, "will have a meaningful impact as the amount of renewable electricity associated with the 1.2 million RECs purchased from Georgia Power is equivalent to the total annual electricity use of more than 100,000 homes in the US”.

The company claims it has already made significant strides with its robust environmental sustainability programme; for example, since its inception in 2019, the company's environment sustainability programme has led to estimated annual savings of more than 1.3 million pounds of C02 and 300,000 gallons of water.

Mentioned Companies
View company profile

Related News